In the United States, someone has a stroke every 40 seconds.[i] Though stroke death rates have declined in recent decades, it is a leading cause of serious long-term disability,[ii] taking a toll on ...

Abnormal reflexes associated with spasticity are considered a major determinant of motor impairments occurring after stroke; however, the mechanisms underlying post-stroke spasticity remain unclear.

New research shows that repeated treatments of botulinum toxin type A (BoNTA) over one year after a stroke can improve muscle tone and reduce pain in the arms and hands, making it easier for patients ...

Spasticity is involuntary overactivity of muscles that occurs following upper motor neuron damage to the brain or spinal cord. Upper limb spasticity is common after stroke and can cause deformity, ...

Extracorporeal Shock Wave Therapy (ESWT) has emerged as a promising non‐invasive technique to manage spasticity, a condition marked by heightened muscle tone and exaggerated tendon reflexes that ...

Spasticity is a disabling complication of stroke, and it is uncertain whether intramuscular injections of botulinum toxin type A reduce disability in persons with spasticity of the wrist and fingers ...

Final results from a multi-center study shows that repeated treatments of botulinum toxin type A (BoNTA or Botox) over one year is well tolerated and results in a significant decrease in spasticity, ...

The design of the study by Brashear et al. of botulinum toxin for stroke (Aug. 8 issue) 1 fails to meet the claim of a “double-blind, placebo-controlled trial.” The investigators were open partners ...

Botulinum toxin type A for treating upper or lower limb focal spasticity associated with stroke [ID768] In development GID-TAG499 Expected publication date: TBC Project information Project documents ...